1-2 of 2
T. Michael Underhill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne, Galen Lambert, Chae Young Shin, Nancy Dos Santos, Krystal A. Orlando, Jessica D. Lang, William P.D. Hendricks, Marcel B. Bally, Anthony N. Karnezis, Ralf Hass, T. Michael Underhill, Gregg B. Morin, Jeffrey M. Trent, Bernard E. Weissman, David G. Huntsman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (12): 2767–2779.
https://doi.org/10.1158/1535-7163.MCT-18-0348
Published: 03 December 2018
View article titled, Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Open the PDF for Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type in another window
Includes: Supplementary data
Journal Articles

Death by HDAC Inhibition in Synovial Sarcoma Cells

Aimée N. Laporte, Neal M. Poulin, Jared J. Barrott, Xiu Qing Wang, Alireza Lorzadeh, Ryan Vander Werff, Kevin B. Jones, T. Michael Underhill, Torsten O. Nielsen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2656–2667.
https://doi.org/10.1158/1535-7163.MCT-17-0397
Published: 03 December 2017
View article titled, Death by HDAC Inhibition in Synovial Sarcoma Cells
Open the PDF for Death by HDAC Inhibition in Synovial Sarcoma Cells in another window
Includes: Supplementary data